A Study Comparing Blood Flow and Clinical and Safety Effects of the Addition of Natrecor (Nesiritide), Placebo or Intravenous Nitroglycerin to Standard Care for the Treatment of Worsening Congestive Heart Failure.

Clinical trial NCT00270374 · COMPLETED

Trial details

NCT number: NCT00270374
Sponsor: Scios, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Symptomatic Decompensated Congestive Heart Failure Congestive Heart Failure in Acute Coronary Syndrome

Start date: 1999-10-01
Enrollment: 498

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.